TherapeuticsMD reported $40.13M in Assets for its fiscal quarter ending in June of 2024.





Assets Change Date
AbbVie USD 136.46B 2.5B Mar/2026
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Cipla INR 424.96B 23.32B Mar/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Novo Nordisk DKK 76.18B 412.98B Jun/2025
Pfizer USD 207.62B 542M Mar/2026
TherapeuticsMD USD 40.13M 1.96M Jun/2024